ReviewExpert review of vaccines2016
The most effective and promising population health strategies to advance human papillomavirus vaccination.
Review in Expert review of vaccines, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Overcoming COVID-19 vaccine hesitancy among ethnic minorities: A systematic review of UK studies.Vaccine · 2022Pooled it
- A narrative review of HPV vaccination interventions in rural U.S. communities.Preventive medicine · 2021Pooled it
- Patient reminder and recall interventions to improve immunization rates.The Cochrane database of systematic reviews · 2018Pooled it
- Evaluating the impact of multilevel evidence-based implementation strategies to enhance provider recommendation on human papillomavirus vaccination rates among an empaneled primary care patient population: a study protocol for a stepped-wedge cluster randomized trial.Implementation science : IS · 2018Trial
- An Exploratory Study of Rural Parents' Knowledge and Attitudes About HPV Vaccination Following a Healthcare Visit With Their Child's Primary Care Provider.Journal of primary care & community healthTrial
- HPV Vaccine Hesitancy in Rural America and Exploring Artificial-Intelligence Interventions.Proceedings of the ... Annual Hawaii International Conference on System Sciences. Annual Hawaii International Conference on System Sciences · 2025Article
- Co-development of a school-based and primary care-based multicomponent intervention to improve HPV vaccine coverage amongst French adolescents (the PrevHPV Study).Health expectations : an international journal of public participation in health care and health policy · 2023Article
- Patient-Provider Health Communication Strategies: Enhancing HPV Vaccine Uptake among Adolescents of Color.Healthcare (Basel, Switzerland) · 2023Article
- Promoting HPV vaccination at school: a mixed methods study exploring knowledge, beliefs and attitudes of French school staff.BMC public health · 2023Article
- Beliefs about HPV vaccination and awareness of vaccination status: Gender differences among Northern Italy adolescents.Preventive medicine reports · 2021Article
- Review the safety of Covid-19 mRNA vaccines: a review.Patient safety in surgery · 2021Review
- Evidence-Based Strategies for Clinical Organizations to Address COVID-19 Vaccine Hesitancy.Mayo Clinic proceedings · 2021Review
- The role of healthcare providers in HPV vaccination programs - A meeting report.Papillomavirus research (Amsterdam, Netherlands) · 2019Article
- Immunization Campaigns and Strategies against Human Papillomavirus in Italy: The Results of a Survey to Regional and Local Health Units Representatives.BioMed research international · 2019Article
- Approaching a decade since HPV vaccine licensure: Racial and gender disparities in knowledge and awareness of HPV and HPV vaccine.Human vaccines & immunotherapeutics · 2017Article
- Variation in Human Papillomavirus Vaccine Uptake and Acceptability Between Female and Male Adolescents and Their Caregivers.Journal of community health · 2017Article
- Article
- Awareness and knowledge of Human Papillomavirus (HPV), HPV-related cancers, and HPV vaccines in an uninsured adult clinic population.Cancer medicine · 2016Article
- Missing the Target for Routine Human Papillomavirus Vaccination: Consistent and Strong Physician Recommendations Are Lacking for 11- to 12-Year-Old Males.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2016Article
- Implementing a Multipartner HPV Vaccination Assessment and Feedback Intervention in an Integrated Health System.Journal of public health management and practice : JPHMPArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The US is failing to make substantive progress toward improving rates of human papillomavirus vaccine uptake. While the Healthy People 2020 goal for human papillomavirus (HPV) vaccination is 80%, the three-dose completion rate in the US in 2014 for 13- to 17-year-old females is less than 40%, and the rate for males is just above 20%. Experts point to a number of reasons for the poor HPV vaccination rates including parental concerns about safety, necessity, and timing. However, the evidence refuting these concerns is substantial. Efforts focusing on education and communication have not shown promise, but several population health strategies have reminder/recall systems; practice-focused strategies targeting staff, clinicians, and parents; assessment and feedback activities; and school-based HPV vaccination programs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.